The People
What Would It Take to Get Peptides on the Shelf?
Peptide therapies have surged in popularity through compounding pharmacies and gray-market sellers, but few have cleared the FDA’s approval path. Regulators and researchers explain what evidence would be required for over-the-counter availability. Doctors warn that unregulated products carry real risks.
Read Full Story at NPR NewsDiscussSoon← Front Page